Akt-2 Is a Potential Therapeutic Target for Disseminated Candidiasis

J Immunol. 2022 Sep 1;209(5):991-1000. doi: 10.4049/jimmunol.2101003. Epub 2022 Aug 5.

Abstract

Akt-1 and Akt-2 are the major isoforms of the serine/threonine Akt family that play a key role in controlling immune responses. However, the involvement of Akt-1 and Akt-2 isoforms in antifungal innate immunity is completely unknown. In this study, we show that Akt2 -/-, but not Akt1 -/-, mice are protected from lethal Candida albicans infection. Loss of Akt-2 facilitates the recruitment of neutrophils and macrophages to the spleen and increases reactive oxygen species expression in these cells. Treating C57BL/6 mice with a specific inhibitor for Akt-2, but not Akt-1, provides protection from lethal C. albicans infection. Our data demonstrate that Akt-2 inhibits antifungal innate immunity by hampering neutrophil and macrophage recruitment to spleens and suppressing oxidative burst, myeloperoxidase activity, and NETosis. We thus describe a novel role for Akt-2 in the regulation of antifungal innate immunity and unveil Akt-2 as a potential target for the treatment of fungal sepsis.

MeSH terms

  • Animals
  • Antifungal Agents
  • Candida albicans*
  • Candidiasis*
  • Mice
  • Mice, Inbred C57BL
  • Neutrophils
  • Peroxidase / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Reactive Oxygen Species / metabolism
  • Serine / metabolism
  • Threonine / metabolism

Substances

  • Antifungal Agents
  • Reactive Oxygen Species
  • Threonine
  • Serine
  • Peroxidase
  • Akt2 protein, mouse
  • Proto-Oncogene Proteins c-akt

Supplementary concepts

  • Systemic candidiasis